Kaleido Scope: UAB Vascular Surgery and Biostatistics partner to lead WARRIORS Clinical Trial
Nasdaq: Humacyte, Inc. Presents Positive Results from Phase 3 Clinical Trial of Acellular Tissue Engineered Vessel at Society for Vascular Surgery Vascular Annual Meeting
Humacyte, Inc. Presents Positive Results from Phase 3 Clinical Trial of Acellular Tissue Engineered Vessel at Society for Vascular Surgery Vascular Annual Meeting
Business Wire: VenoStent Embarks on Clinical Trial to Improve Success Rate of Vascular Surgery Outcomes
VenoStent Embarks on Clinical Trial to Improve Success Rate of Vascular Surgery Outcomes
Nasdaq: Humacyte Announces Clinical Case Series Demonstrating Potential of Human Acellular Vessel™ (HAV™) to Expand Opportunities for Limb Salvage in Multiple Complex Vascular ...
Humacyte Announces Clinical Case Series Demonstrating Potential of Human Acellular Vessel™ (HAV™) to Expand Opportunities for Limb Salvage in Multiple Complex Vascular ...
Endovascular Today: Building a Modern Neurovascular Center of Excellence: Experience at the Gates Vascular Institute and the University at Buffalo Neurosurgery
Lessons from a multidisciplinary, high-volume center integrating clinical care, translational science, technologic innovation, and scientific investigation across the full continuum of neurovascular ...
Building a Modern Neurovascular Center of Excellence: Experience at the Gates Vascular Institute and the University at Buffalo Neurosurgery
Medical Xpress: Scientists create universal vascular graft with stem cells to improve surgery for cardiovascular disease
Scientists create universal vascular graft with stem cells to improve surgery for cardiovascular disease
Becker's Hospital Review: The ROI Hidden in Plain Sight: What Health Executives Need to Know About Vascular Surgery
The ROI Hidden in Plain Sight: What Health Executives Need to Know About Vascular Surgery